Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Illumina Names Paul Bianchi as Senior Vice President of Human Resources

Published: Wednesday, December 19, 2012
Last Updated: Tuesday, December 18, 2012
Bookmark and Share
Bianchi to join Illumina executive team to execute world-class human capital strategy.

Illumina, Inc. has announced that it has appointed Paul Bianchi as Senior Vice President of Human Resources.

In this executive management position, Bianchi will oversee Illumina's global HR strategy and programs including talent and leadership development, employee engagement and communications, and rewards and recognition.

Based in the San Francisco Bay Area, he will also assume responsibility for site management of Illumina's Hayward office.

"Paul has an impressive track record of driving organizational and human capital development at some of the world's leading technology companies," said Jay Flatley, President and Chief Executive Officer of Illumina.

Flatley continued, "We are excited to welcome him to our growing organization, and value the expertise he brings in developing teams, building management and leadership capacity, and supporting rapid growth and change."

Bianchi is a human capital executive with over 20 years of leadership experience with innovative companies. He joins Illumina from Risk Management Solutions, where he served as SVP of Human Resources for a growing, global leader of catastrophe risk software.

Previously, Bianchi was a Principal at Strayer Consulting services where he delivered organizational development services to a wide variety of clients from small start-ups to multi-billion dollar companies.

Prior to this, he served as global leader of human resources for PeopleSoft, Hands-On Mobile, Ask Jeeves, ProBusiness Services, and NeXT Computer, as well as in a key management position with Apple.

His expertise also includes leading due diligence and integration efforts for over a dozen acquisitions ranging from $50M to $1.5B.

Bianchi has a Master's in Management from the University of Kent, Canterbury (UK) and a Bachelor of Science in Managerial Economics, with a Minor in Rhetoric, from the University of California, Davis.

He has been certified as a Senior Professional in HR, has taught at San Jose State University, and has spoken on a variety of topics at software and human resources forums.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Illumina Applies CE Mark to VeriSeq™ NIPT Analysis Software
Company has announced that it has applied the CE mark to expand the use of VeriSeq NIPT analysis software in clinical laboratories.
Thursday, February 25, 2016
Genomics England, Illumina Enter Bioinformatics Partnership
Illumina, and Genomics England have announced a partnership to develop a platform and knowledge base that can be used to improve and automate genome interpretation.
Thursday, February 11, 2016
Desktop Genetics Receives Strategic Investment from Illumina
Illumina invests in Desktop Genetics' technology to support the platform's integration with NGS pipelines and improve CRISPR genome editing workflows.
Thursday, December 10, 2015
Illumina to Acquire GenoLogics
Illumina has signed a definitive agreement to acquire GenoLogics, a developer of LIMS for life science organizations.
Wednesday, August 05, 2015
Illumina Names Sanjay Chikarmane as SVP and General Manager
Chikarmane will report to Illumina President, Francis deSouza.
Tuesday, July 21, 2015
Berry, Illumina Co-Develop NGS System for CFDA Review and Approval
Berry Genomics will use Illumina’s NGS technology to secure Chinese Food and Drug Administration regulatory approval for clinical applications, expanding access to NGS-based tests in China.
Monday, July 21, 2014
Illumina Signs Agreement to Acquire NextBio
Acquisition will strengthen Illumina's informatics portfolio, enable accelerated adoption of next-generation sequencing in current and new markets.
Tuesday, October 29, 2013
Illumina Announces BaseSpace® Pricing for Data Storage and Processing
Breaks analysis cost bottleneck for next generation sequencing workflow.
Thursday, December 27, 2012
Malaysian Genomics Resource Centre Berhad Launches US$4000 Human Genome Bioinformatics Service
New service is designed to analyze human genome data from Illumina's Genome Analyzer or Complete Genomics' DNA sequencing platform.
Tuesday, April 06, 2010
Scientific News
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
Making Genetic Data Easier to Search
Scripps team streamlines biomedical research by making genetic data easier to search.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Characterizing Cancerous Genomic Variations
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Uncovering Hidden Genomic Alterations that Drive Cancers
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function.
Spotting DNA Repair Genes Gone Awry
Ludwig researchers develop a two-pronged approach for identifying genes responsible for fixing DNA damage that can trigger cancer when compromised.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!